A randomized-controlled trial of high- or low-volume intravenous Plasma-Lyte(®) to prevent hypotension during sedation for colonoscopy

Can J Anaesth. 2016 Aug;63(8):952-61. doi: 10.1007/s12630-016-0672-4. Epub 2016 May 18.

Abstract

Purpose: The purpose of this study was to compare the incidence of hypotension during sedation in adults presenting for elective colonoscopy and randomized to intravenous Plasma-Lyte 148(®) at either 2 mL·kg(-1) (low volume) or 20 mL·kg(-1) (high volume).

Methods: Patients aged ≥ 18 yr presenting for elective colonoscopy, with or without gastroscopy, after oral bowel preparation were randomized to receive the intervention immediately before the start of the procedure. Hypotension was defined as a ≥ 25% decrease in systolic blood pressure (SBP) from baseline during the procedure. Secondary outcomes included SBP < 90 mmHg, lowest SBP during sedation, duration of hypotension, use of vasopressors, postoperative outcomes, and cost.

Results: Seventy-five patients were randomly allocated to either the low-volume or high-volume group, respectively (total n = 150). The incidence of hypotension was similar in the two groups (59% vs 56%, respectively; odds ratio, 0.90; 95% confidence interval, 0.47 to 1.71; P = 0.74). The incidence of SBP < 90 mmHg, the lowest SBP during sedation, the duration of hypotension, the use of vasopressors, and postoperative outcomes were also similar in the two groups.

Conclusions: This study does not support the routine use of 20 mL·kg(-1) of intravenous Plasma-Lyte 148 to prevent hypotension and other complications during sedation for elective colonoscopy in adult patients. Clinical Trials Registry (ANZCTR 12615001288516).

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Anesthesia / adverse effects*
  • Blood Pressure / drug effects
  • Colonoscopy*
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Female
  • Gluconates / administration & dosage
  • Gluconates / therapeutic use
  • Humans
  • Hypotension / prevention & control*
  • Magnesium Chloride / administration & dosage
  • Magnesium Chloride / therapeutic use
  • Male
  • Middle Aged
  • Potassium Chloride / administration & dosage
  • Potassium Chloride / therapeutic use
  • Sodium Acetate / administration & dosage
  • Sodium Acetate / therapeutic use
  • Sodium Chloride / administration & dosage
  • Sodium Chloride / therapeutic use

Substances

  • Gluconates
  • Plasma-lyte 148
  • Magnesium Chloride
  • Sodium Chloride
  • Sodium Acetate
  • Potassium Chloride